MedPath
NMPA Approval

Lamotrigine Dispersible Tablets

国药准字HJ20180092

November 4, 2022

H20180092

Drug Information

拉莫三嗪分散片

利必通

片剂

100mg

化学药品

November 4, 2022

November 3, 2027

Company Information

Applicant Company

980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom

Manufacturing Company

delpharm poznan spolka akcyjna

Ulica Grunwaldzka 189, Poznan, PL-60-322, Poland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

拉莫三嗪分散片 - NMPA 批准文号 | MedPath